Landmark Cars Limited Share Price & Analysis

L&T wins major order to build Nvidia AI factory

*L&T wins major order to build Nvidia AI factory.* L&T has secured a significant project to construct an AI-focused semiconductor facility for Nvidia in India. This landmark order underscores L&T’s growing role in high-tech infrastructure. The contract value is estimated at **₹2,500 crore**. 📊 *STOCKS:* $LT | 🏢 *SECTOR:* CapitalMarkets | #HIGHIMPACT #L&T

Fairfax leads race for IDBI Bank stake sale

*Fairfax emerges frontrunner for IDBI Bank stake sale.* The proposed **$5.5 billion** deal marks a landmark in India's public sector privatisation drive. A successful transaction could significantly reshape the bank’s ownership and governance. The move may trigger investor interest in other PSU divestments. 📊 *STOCKS:* IDBI | 🏢 *SECTOR:* Banking | #HIGHIMPACT #Privatisation

India's largest IPO set to launch this year

*India's largest IPO set to launch this year.* This landmark offering marks a major milestone in the country's capital markets. Though the company hasn't been named, the IPO is expected to raise **over $10 billion**, surpassing previous records. Investor interest is likely to be intense across retail and institutional segments. 📊 *STOCKS:* | 🏢 *SECTOR:* CapitalMarkets | #HIGHIMPACT #IPO

Royalty on crude, gas slashed in landmark reform

Hardeep Puri announced a major rationalisation of royalty rates for crude oil, natural gas, and condensate, marking a landmark reform in upstream policy. The new structure reduces royalty to **5%** for onshore and shallow water fields from **12.5–13%**, and to **7.5%** for deepwater areas. This is expected to boost private investment and production in India’s domestic energy sector. 📊 *STOCKS:* | 🏢 *SECTOR:* Energy | #HIGHIMPACT #Energy

Sun Pharma to acquire Organon's India business in $12B deal

*Sun Pharma to acquire Organon's India business in $12B deal* — This landmark $12 billion transaction marks one of the largest in India’s pharma sector. The deal will significantly expand Sun Pharma’s portfolio and market reach. It includes Organon’s women’s health and specialty brands. The acquisition is expected to close by 2025 pending regulatory approvals. 📊 *STOCKS:* SUNPHARMA | 🏢 *SECTOR:* Pharma | #HIGHIMPACT #Mergers

SDHI wins ₹2,600 crore ammonia dual-fuel bulk carrier order

*SDHI wins India's first ammonia dual-fuel bulk carrier order worth over ₹2,600 crore.* This landmark order represents a significant contract win for the domestic shipping sector and demonstrates India's push toward sustainable marine solutions. The dual-fuel capability positions SDHI favorably in the evolving global shipping landscape focused on decarbonization. 📊 *STOCKS:* SDHI | 🏢 *SECTOR:* Shipping | #HIGHIMPACT #OrderWin

NSE IPO speculation: world's largest exchange mulls public listing

*NSE India IPO: Is the World's Largest Exchange Finally Ready.* Speculation intensifies around a potential IPO of the National Stock Exchange, the world's largest derivatives exchange by volume. A public listing could unlock significant value for stakeholders and enhance transparency in India's capital markets infrastructure. The move would mark a landmark event in Indian financial markets. 📊 *SECTOR:* CapitalMarkets | #HIGHIMPACT #IPO

Aerolloy Technologies signs Airbus titanium supply deal

*Aerolloy Technologies signs Airbus titanium supply deal*. A subsidiary of PTC Industries, Aerolloy, has secured a long-term agreement to supply titanium castings for Airbus’ A320neo, A330neo, and A350 aircraft programmes. This landmark deal strengthens PTC’s position in global aerospace supply chains. The contract is expected to boost revenue with deliveries starting in **2027**. 📊 *STOCKS:* $PTC | 🏢 *SECTOR:* CapitalMarkets | #MEDIUMIMPACT #Aerospace

Kolte-Patil announces ₹6,000 crore Mumbai project expansion

*Kolte-Patil announces ₹6,000 crore Mumbai project expansion.* The company has signed six new projects in Mumbai with a total GDV of **₹6,000 crore**, marking a significant expansion in the region. This move strengthens its presence in the high-demand Mumbai real estate market. The development is a key milestone in its growth strategy. 📊 *STOCKS:* $KOLTEPATIL | 🏢 *SECTOR:* Realty | #MEDIUMIMPACT #RealEstate

Glenmark advances Phase 3 trial for ovarian cancer drug

*Glenmark advances Phase 3 trial for ovarian cancer drug*. The company has progressed its multi-country Phase 3 clinical trial of Trastuzumab rezetecan in platinum-resistant ovarian cancer. This advancement signals positive momentum in its oncology pipeline. **Phase 3 trials** are pivotal for regulatory approval and market potential. 📊 *STOCKS:* GLENMARK | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #ClinicalTrial